High MET gene copy number leads to shorter survival in patients with non-small cell lung cancer.
about
Molecular biology of lung cancerTyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical ImplicationsBiomarker development in MET-targeted therapyDysregulation of the Met pathway in non-small cell lung cancer: implications for drug targeting and resistanceMET gene copy number predicts worse overall survival in patients with non-small cell lung cancer (NSCLC); a systematic review and meta-analysisDurable complete response of metastatic gastric cancer with anti-Met therapy followed by resistance at recurrence.Reinventing diagnostics for personalized therapy in oncologyPhase 1 dose-escalation trial evaluating the combination of the selective MET (mesenchymal-epithelial transition factor) inhibitor tivantinib (ARQ 197) plus erlotinib.Prognostic value of MET gene copy number and protein expression in patients with surgically resected non-small cell lung cancer: a meta-analysis of published literaturesIntegrated analyses of copy number variations and gene expression in lung adenocarcinomaDetection of kinase amplifications in gastric cancer archives using fluorescence in situ hybridization.Targeting MET Amplification as a New Oncogenic Driver.Pulmonary adenocarcinoma: implications of the recent advances in molecular biology, treatment and the IASLC/ATS/ERS classification.Increased MET Gene Copy Number but Not mRNA Level Predicts Postoperative Recurrence in Patients with Non-Small Cell Lung CancerHow close are we to customizing chemotherapy in early non-small cell lung cancer?MET phosphorylation predicts poor outcome in small cell lung carcinoma and its inhibition blocks HGF-induced effects in MET mutant cell linesComprehensive Molecular Analysis of NSCLC; Clinicopathological AssociationsFrequent gene amplification predicts poor prognosis in gastric cancer.Correlation between MET gene copy number by silver in situ hybridization and protein expression by immunohistochemistry in non-small cell lung cancer.MET in gastric carcinomas: comparison between protein expression and gene copy number and impact on clinical outcome.Genetic changes in squamous cell lung cancer: a reviewDetection of MET and SOX2 amplification by quantitative real-time PCR in non-small cell lung carcinoma.Expression of c-Met Is Different along the Location and Associated with Lymph Node Metastasis of Head and Neck CarcinomaPrognostic value of MET, cyclin D1 and MET gene copy number in non-small cell lung cancerApproaches to uncovering cancer diagnostic and prognostic molecular signaturesA phase I dose-escalation study of LY2875358, a bivalent MET antibody, given as monotherapy or in combination with erlotinib or gefitinib in Japanese patients with advanced malignancies.The impact of genomic changes on treatment of lung cancer.Alteration status and prognostic value of MET in head and neck squamous cell carcinoma.Update on the Treatment of Metastatic Squamous Non-Small Cell Lung Cancer in New Era of Personalized Medicine.c-MET as a potential therapeutic target and biomarker in cancer.MET: a promising anticancer therapeutic target.Comparison of the efficacy and safety of single-agent erlotinib and doublet molecular targeted agents based on erlotinib in advanced non-small cell lung cancer (NSCLC): a systematic review and meta-analysis.Lung cancer in never-smokers. Does smoking history matter in the era of molecular diagnostics and targeted therapy?Receptor tyrosine kinase alterations and therapeutic opportunities in squamous cell carcinoma of the lung.Republished: lung cancer in never-smokers. Does smoking history matter in the era of molecular diagnostics and targeted therapy?Targeting the MET receptor tyrosine kinase in non-small cell lung cancer: emerging role of tivantinibMET inhibition in lung cancer.Prognostic and predictive biomarkers in early stage non-small cell lung cancer: tumor based approaches including gene signaturesPrognostic and predictive value of MET deregulation in non-small cell lung cancerCurrent and future molecular diagnostics in non-small-cell lung cancer.
P2860
Q24606677-7BB77499-6624-4BE9-9CD4-9B8C18D505D7Q26741318-F85C4572-0A92-4E2A-AB0B-9A0F6BFD1AAFQ26751332-A4FD3B05-D28D-44FD-9EA0-AC4696EE0E93Q26799900-80A0824E-0A78-4329-BB10-DC2C52769F9CQ26823626-B2EDFC7D-18CB-4537-AF31-D1224AE6CE88Q27851725-A1E310C9-A809-442F-86E7-AC1F8D1B42A3Q28391395-324A3F64-B072-4BFE-A8FF-C6B3C797AA2BQ33161299-9B9484D7-3999-4291-B703-00888881D6C5Q33748638-79F81EEA-ADE5-4F6C-973E-4F65DD2F25AEQ34026325-C44DAC62-AB75-4CFD-A3EF-E6B3C7A8A0C6Q34301120-CC4F4D4E-0DD9-4869-A572-5FF7D5D2D28AQ34309927-7A2DCE44-D885-4F34-8604-7E7D06735CD5Q34404209-815D7140-5445-49D7-B21D-867522EFD762Q34478374-8E408AFC-4B2C-4FC5-9155-AE8727B56A0EQ35146944-A7315A99-80C6-4A61-B75C-7B2A83932224Q35208173-0A947D52-E076-405B-9B6D-53EB63DE4798Q35712214-FDEDF818-1708-41F3-8450-FFEF149298B6Q35933994-2766171D-0B92-44C3-96C6-792A9A914513Q35983145-DDEC379A-21EE-4672-BD24-55265716BEDBQ36089948-8D4E8308-38D5-4E63-98C5-E3896E9B0D23Q36115735-A287E67D-C982-4E8F-A77C-1892627B1613Q36135757-51E23183-1067-447C-AE34-A2B1BD27BA17Q36518737-14D9CE9D-5328-4488-82B1-E8A3B93A9085Q36878125-2D8FC456-7685-461C-8164-8B0CBE70FFB5Q36997737-175D4374-4036-4559-8C71-6AFA876B5710Q37222790-9EFB37A5-55AB-45C2-9196-D31C03B217EBQ37304354-3457BAAA-6CF1-4F05-AF9E-A82FD5654A06Q37514050-5BD63CD8-C17C-4C39-B512-F7BCF51F791BQ37721218-B0C4C26A-D1B5-4928-9A50-5E39763D9BD1Q37962905-722D4E7D-42B0-4E36-9463-E5CB65ED7FB6Q38008247-35872DC2-42CE-486D-9C36-0C5C9494579AQ38091669-411FF671-09C2-448F-8282-D6E6713EF7D2Q38105532-95BAE48B-78BA-46D4-8537-8C3FAD84E4D0Q38130137-7D67698B-4F69-4476-9FD6-3E0C08F6D9ADQ38197071-2CD07D5F-DAC7-4528-B8E0-AFF58F9B3114Q38261315-9CA1624D-4344-433B-9BE5-DAE598B6403FQ38390016-E7284844-45CB-4236-B88A-FBCD74F37171Q38390072-A906620E-29AA-47AC-87D6-9E019D94E36AQ38493294-B0DDA71E-9001-4DA9-9FCB-98EF4CD96990Q38543780-8EE14A87-91B8-4C71-9D8F-77E91198703A
P2860
High MET gene copy number leads to shorter survival in patients with non-small cell lung cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
High MET gene copy number lead ...... th non-small cell lung cancer.
@en
High MET gene copy number lead ...... th non-small cell lung cancer.
@nl
type
label
High MET gene copy number lead ...... th non-small cell lung cancer.
@en
High MET gene copy number lead ...... th non-small cell lung cancer.
@nl
prefLabel
High MET gene copy number lead ...... th non-small cell lung cancer.
@en
High MET gene copy number lead ...... th non-small cell lung cancer.
@nl
P2093
P1476
High MET gene copy number lead ...... ith non-small cell lung cancer
@en
P2093
Doo Hyun Chung
Heounjeong Go
Hyo Jin Park
Sook-Whan Sung
Yoon Kyung Jeon
P304
P356
10.1097/JTO.0B013E3181CE3D1D
P577
2010-03-01T00:00:00Z